A project selected in the Decrypthon program has been launched on the World Community Grid, coordinated by IBM. After successful tests on the university grid, the molecular docking project coordinated by Alessandra Carbone (Université Pierre et Marie Curie / Unité Inserm 511) will take advantage of the second level of the Decrypthon program: the computational power of approximately 500 000 internet users' PCs.

Sixteen months after launching the Decrypthon program in March 2005, the three founder partners, presented to the scientific community, the projections and developments of the program during the JOBIM 2006 (Journées Ouvertes de Biologie Informatique et Mathématiques), a meeting on bioinformatics which took place from the 5-7 July 2006.

After the first two projects with which the platform of the Decrypthon Program started, a call for proposals was launched in December 2004 to select new projects for 2005. An expertise, independent of each pre-selected project, by two biologists and two bioinformatic specialists or grid computing specialists allowed to select three new projects. A funding agreement for these projects was granted on June 16th after approval by the Decrypthon board of directors, the AFM Scientific Board and the AFM Administrative Board (on June 16th).

The University of Bordeaux 1 constitutes one of the pillars of this exciting national challenge. The powerful computation competences and its technical skills will be available for the Decrypthon Program.

Speeding up genomics and proteomics research thanks to Grid Computing technologies

Technological innovation, in particular data-processing, can fulfil new requirements in genetic research, 3 major role-players in their fields, the AFM, a patients’ association, the CNRS, a research organization, and IBM, computer science company, have launched the Decrypthon program, a Grid Computing platform.
Objective: to accelerate genomic and proteomic research in order to advance more quickly in the comprehension of genetic diseases, particularly neuromuscular diseases.